These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. 28th Annual JPMorgan Healthcare Conference--Exelixis and Nektar Therapeutics. Gale S; Croasdell G IDrugs; 2010 Mar; 13(3):139-41. PubMed ID: 20191424 [TBL] [Abstract][Full Text] [Related]
10. 28th Annual JPMorgan Healthcare Conference--Human Genome Sciences and Celgene. Gale S; Croasdell G IDrugs; 2010 Mar; 13(3):135-8. PubMed ID: 20191423 [TBL] [Abstract][Full Text] [Related]
11. American society of clinical oncology - 45th annual meeting. Part 2. Lakeram M; Kibble A IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155 [No Abstract] [Full Text] [Related]
12. American society of clinical oncology - 45th annual meeting. Part 1. Gale S IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154 [No Abstract] [Full Text] [Related]
13. Neoadjuvant trials could speed up drug approvals. Peres J J Natl Cancer Inst; 2014 Mar; 106(3):dju072. PubMed ID: 24610911 [No Abstract] [Full Text] [Related]
15. From the analyst's couch: Next-generation antibodies. Evans JB; Syed BA Nat Rev Drug Discov; 2014 Jun; 13(6):413-4. PubMed ID: 24722461 [No Abstract] [Full Text] [Related]
16. Discontinued drugs in 2008: oncology drugs. Williams R Expert Opin Investig Drugs; 2009 Nov; 18(11):1581-94. PubMed ID: 19663760 [TBL] [Abstract][Full Text] [Related]
17. First new lupus drug approved in half-century. Thompson CA Am J Health Syst Pharm; 2011 Apr; 68(8):646. PubMed ID: 21460166 [No Abstract] [Full Text] [Related]
18. Clinical approval success rates for investigational cancer drugs. DiMasi JA; Reichert JM; Feldman L; Malins A Clin Pharmacol Ther; 2013 Sep; 94(3):329-35. PubMed ID: 23739536 [TBL] [Abstract][Full Text] [Related]